Similarly, in the presence of BMP4, the predominant ligand that regulates pulmonary vascular smooth muscle homeostasis, SMURF1 inhibition reduced proliferation and migration of primary PASMCs from patients with PAH (Figures 4J–4M). Here, BMP4 is linked to pulmonary arterial hypertension.